Skip to main content
. 2020 Mar 30;69(7):1363–1373. doi: 10.1007/s00262-020-02551-6

Fig. 3.

Fig. 3

10-year EFS of the overall cohort stratified by TP53 mutation type (blue and yellow lines) and nonmutated (wild type) tumors (red line). Dashed lines indicate median EFS for each stratum